All About ED Treatment
About Erectile Dysfunction
- The companies that distribute Cialis, Levitra and Viagra had revenues of over $4+ billion in 2012. Not even half of the men that suffer from ED saw any kind of relief from these ED medications and all had horrible and serious side effects.
- Most men with mild (ED) Erectile Dysfunction, or with no ED signs at all, take these pills as sexual supplements to promise stronger sexual stamina.
- Men with severe ED are contenders for micro-penile injections that consist of three or four vasodilators. These medications usually have side effects that even more serious than oral medications.
- There is a new cure available. Our groundbreaking Acoustic Wave Therapy Protocol uses acoustical pulse waves to release existing blood vessels, grow new blood vessels, and promote stem cells to grow new erectile tissue (corpus cavernosum) in the penis.
- Contingent on a man’s overall health and preexisting conditions, this noninvasive treatment option will dramatically improve erectile dysfunction and performance.
- Independent, published research papers verify its safety and effectiveness, with 86% of men saying they have recommended the treatment to a family member or friend.
- We have full confidence in our treatment and have seen time and time again how it moves the clock backwards for most men, allowing men of ages up to 90 peform as they did in their younger years.
Clinical Research for ED
Shockwave Treatment Of
LI-ESWT (Low Intensity – Extracorporeal Shock Wave Therapy) is a innovative treatment of ED and has exceptional qualities that rehabilitate erectile tissue. The clinical advancement in subjective erectile function together with the noteworthy enhancement in penile hemodynamics following LI-ESWT confirms that LI-ESWT has distinguishing properties that create a new standard of care for men with ED.
LI-ESWT is both possible and bearable and without any adverse or unwanted effects. Its main benefit is its ability to completely treat and restore erectile function in men with ED without additional pharmacotherapy. Hence, LI-ESWT is an appealing addition to the armamentarium of existing treatment options for ED. Soon, we hope that LI-ESWT will be used for the long-term clinical management of ED either as another or as an enhancer to the current treatments of ED.
International Journal of Andrology
Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial
The Canadian Journal of Urology
Low-intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population
Bulletin of Experimental Biology and Medicine
Efficiency Assessment of Shock Wave Therapy in Patients with Pelvic Pain Employing Harmonic Analysis of Penile Bioimpedance
International Journal of Impotence Research
Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study
European Association of Urology
Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis
International Society for Sexual Medicine
Low Intensity Extracorporeal Shock Wave Therapy—A Novel Effective Treatment for Erectile Dysfunction in Severe ED Patients Who Respond Poorly to PDE5 Inhibitor Therapy
European Urology Vardi
Can Low Intensity Extracorporeal Shockwave Therapy Improve Erectile Function? A 6-Month Follow-up Pilot Study in Patients with Organic Erectile Dysfunction
European Urology Mirone
Our Experience on the Association of a New Physical and Medical Therapy in Patients Suffering from Induratio penis plastica
International Journal of Urology
Impact of aging and comorbidity on the efficacy of low-intensity shock wave therapy for erectile dysfunction
Peyronie’s disease the Plymouth experience of extracorporeal shockwave treatment
The Journal of Urology
Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study
American Society of Andrology and European Academy of Andrology
Therapeutic advances in the treatment of Peyronie’s disease
The Authors – BJU International
Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial
Men’s Power-Pressure Wave Erectile Regeneration-Therapy